Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HMGA Proteins | 1 | 2017 | 1 | 0.71 | Why? |
| MAP Kinase Kinase 1 | 1 | 2017 | 14 | 0.70 | Why? |
| Cholangiocarcinoma | 2 | 2017 | 186 | 0.69 | Why? |
| Histiocytosis, Sinus | 1 | 2017 | 25 | 0.69 | Why? |
| Bile Duct Neoplasms | 2 | 2017 | 172 | 0.69 | Why? |
| Drug Resistance, Neoplasm | 2 | 2017 | 447 | 0.64 | Why? |
| Carcinoma, Hepatocellular | 6 | 2018 | 1222 | 0.63 | Why? |
| Pathology, Molecular | 1 | 2019 | 343 | 0.62 | Why? |
| Carcinogenesis | 2 | 2017 | 236 | 0.61 | Why? |
| Hepatocytes | 3 | 2017 | 549 | 0.60 | Why? |
| Liver Neoplasms | 6 | 2018 | 1666 | 0.55 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.54 | Why? |
| Liver | 5 | 2018 | 4007 | 0.40 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1014 | 0.25 | Why? |
| Tumor Microenvironment | 3 | 2017 | 264 | 0.22 | Why? |
| Choroid Diseases | 1 | 2021 | 35 | 0.22 | Why? |
| Immunoconjugates | 1 | 2019 | 90 | 0.19 | Why? |
| Inorganic Pyrophosphatase | 1 | 2018 | 1 | 0.19 | Why? |
| Lipogenesis | 1 | 2018 | 49 | 0.19 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.19 | Why? |
| Smad Proteins | 1 | 2017 | 19 | 0.18 | Why? |
| Insulin-Secreting Cells | 1 | 2021 | 273 | 0.18 | Why? |
| Dirofilariasis | 1 | 2017 | 7 | 0.18 | Why? |
| Histidine | 1 | 2018 | 72 | 0.18 | Why? |
| Gene Expression | 2 | 2020 | 3332 | 0.18 | Why? |
| Varicocele | 1 | 2017 | 11 | 0.18 | Why? |
| Neuropilin-1 | 1 | 2021 | 284 | 0.18 | Why? |
| Cell Nucleus Size | 1 | 2017 | 9 | 0.18 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.17 | Why? |
| Kupffer Cells | 1 | 2017 | 34 | 0.17 | Why? |
| Scrotum | 1 | 2017 | 48 | 0.17 | Why? |
| Telomere Homeostasis | 1 | 2017 | 52 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2017 | 93 | 0.17 | Why? |
| Microglia | 1 | 2020 | 357 | 0.16 | Why? |
| Tumor Suppressor Proteins | 1 | 2018 | 165 | 0.16 | Why? |
| Deoxycytidine | 1 | 2017 | 116 | 0.16 | Why? |
| Cell Line, Tumor | 4 | 2017 | 3608 | 0.16 | Why? |
| Neoplastic Stem Cells | 1 | 2017 | 120 | 0.16 | Why? |
| Imatinib Mesylate | 1 | 2018 | 327 | 0.15 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.15 | Why? |
| Retinal Diseases | 1 | 2021 | 441 | 0.15 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.14 | Why? |
| Histones | 1 | 2017 | 371 | 0.14 | Why? |
| Colorectal Neoplasms | 2 | 2019 | 1884 | 0.14 | Why? |
| Eye Infections, Viral | 1 | 2021 | 517 | 0.13 | Why? |
| Epigenesis, Genetic | 1 | 2019 | 711 | 0.12 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.12 | Why? |
| Extracellular Traps | 1 | 2021 | 1036 | 0.12 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2019 | 830 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Lung Injury | 1 | 2021 | 919 | 0.12 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.11 | Why? |
| Antineoplastic Agents | 2 | 2017 | 3550 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.10 | Why? |
| Autopsy | 4 | 2021 | 3495 | 0.10 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.10 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.09 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.09 | Why? |
| Immunohistochemistry | 3 | 2021 | 2275 | 0.09 | Why? |
| Mice | 5 | 2019 | 21357 | 0.09 | Why? |
| In Situ Hybridization | 2 | 2021 | 390 | 0.09 | Why? |
| Lung | 6 | 2021 | 31049 | 0.09 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Antigens, CD | 2 | 2021 | 984 | 0.08 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.07 | Why? |
| Cell Proliferation | 3 | 2017 | 1973 | 0.07 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.07 | Why? |
| Phosphorylation | 2 | 2018 | 1060 | 0.07 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.07 | Why? |
| Lymph Nodes | 2 | 2021 | 1060 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Humans | 25 | 2021 | 930598 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Ciliary Body | 1 | 2021 | 12 | 0.06 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Receptors, Transferrin | 1 | 2021 | 72 | 0.06 | Why? |
| Animals | 7 | 2019 | 78931 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Caspase 3 | 1 | 2021 | 218 | 0.05 | Why? |
| Peroxidase | 1 | 2021 | 207 | 0.05 | Why? |
| Neuropathology | 1 | 2020 | 95 | 0.05 | Why? |
| GPI-Linked Proteins | 1 | 2021 | 317 | 0.05 | Why? |
| HCT116 Cells | 1 | 2019 | 83 | 0.05 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2021 | 202 | 0.05 | Why? |
| Endothelial Cells | 2 | 2021 | 2048 | 0.05 | Why? |
| Goblet Cells | 1 | 2020 | 181 | 0.05 | Why? |
| Choroid | 1 | 2021 | 112 | 0.05 | Why? |
| Cilia | 1 | 2020 | 183 | 0.05 | Why? |
| Fibrin | 1 | 2021 | 145 | 0.05 | Why? |
| Heterografts | 1 | 2019 | 203 | 0.05 | Why? |
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 22 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| DNA, Neoplasm | 1 | 2018 | 56 | 0.05 | Why? |
| Dirofilaria repens | 1 | 2017 | 4 | 0.05 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.05 | Why? |
| Tissue Fixation | 1 | 2018 | 85 | 0.05 | Why? |
| Paraffin Embedding | 1 | 2018 | 105 | 0.05 | Why? |
| Butylated Hydroxyanisole | 1 | 2017 | 5 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2021 | 472 | 0.04 | Why? |
| Tissue Array Analysis | 1 | 2017 | 75 | 0.04 | Why? |
| Astrocytes | 1 | 2020 | 298 | 0.04 | Why? |
| RNA, Neoplasm | 1 | 2017 | 34 | 0.04 | Why? |
| Formaldehyde | 1 | 2018 | 135 | 0.04 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2017 | 40 | 0.04 | Why? |
| Chromosomes, Human, Pair 6 | 1 | 2017 | 14 | 0.04 | Why? |
| Retinal Vessels | 1 | 2021 | 255 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2021 | 3788 | 0.04 | Why? |
| Genetic Engineering | 1 | 2019 | 325 | 0.04 | Why? |
| Gene Amplification | 1 | 2017 | 85 | 0.04 | Why? |
| Gene Dosage | 1 | 2017 | 101 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.04 | Why? |
| Trans-Activators | 1 | 2017 | 170 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Cornea | 1 | 2021 | 410 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Microscopy, Confocal | 1 | 2017 | 343 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Transforming Growth Factor beta | 1 | 2017 | 363 | 0.04 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.04 | Why? |
| Conjunctiva | 1 | 2021 | 620 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.03 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.03 | Why? |
| Sinusitis | 1 | 2020 | 649 | 0.03 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Insulin | 1 | 2021 | 1316 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Apoptosis | 1 | 2021 | 2335 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.03 | Why? |
| Molecular Targeted Therapy | 1 | 2019 | 1579 | 0.03 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.03 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2021 | 3803 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.02 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| India | 1 | 2017 | 11875 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
Matter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(113)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_